Please use this identifier to cite or link to this item:
Title: Complement Factor D (adipsin) Levels Are Elevated in Acquired Partial Lipodystrophy (Barraquer-Simons syndrome)
Author: Corvillo, Fernando
González-Sánchez, Laura
López-Lera, Alberto
Arjona, Emilia
Ceccarini, Giovanni
Santini, Ferruccio
Araújo-Vilar, David
Brown, Rebecca J.
Villarroya i Terrade, Joan
Villarroya i Gombau, Francesc
Rodríguez de Córdoba, Santiago
Caballero, Teresa
Nozal, Pilar
López-Trascasa, Margarita
Keywords: Oftalmopaties
Teixit adipós
Adipose tissues
Issue Date: 21-Jun-2021
Publisher: MDPI
Abstract: Complement overactivation has been reported in most patients with Barraquer-Simons syndrome (BSS), a rare form of acquired partial lipodystrophy. Complement Factor D (FD) is a serine protease with a crucial role in the activation of the alternative pathway of the complement system, which is mainly synthesized by adipose tissue. However, its role in the pathogenesis of BSS has not been addressed. In this study, plasma FD concentration was measured in 13 patients with BSS, 20 patients with acquired generalized lipodystrophy, 22 patients with C3 glomerulopathy (C3G), and 50 healthy controls. Gene expression and immunohistochemistry studies were assayed using atrophied adipose tissue from a patient with BSS. We found significantly elevated FD levels in BSS cases compared with the remaining cohorts (p < 0.001). There were no significant differences in FD levels between sexes but FD was strongly and directly associated with age in BSS (r = 0.7593, p = 0.0036). A positive correlation between FD and C3 was seen in patients with C3G, characterized by decreased FD levels due to chronic C3 consumption, but no correlation was detected for BSS. Following mRNA quantification in the patient's adipose tissue, we observed decreased CFD and C3 but elevated C5 transcript levels. In contrast, the increased FD staining detected in the atrophied areas reflects the effects of persistent tissue damage on the adipose tissue, thus providing information on the ongoing pathogenic process. Our results suggest that FD could be a reliable diagnostic biomarker involved in the pathophysiology of BSS by promoting unrestrained local complement system activation in the adipose tissue environment
Note: Reproducció del document publicat a:
It is part of: International Journal of Molecular Sciences, 2021, vol. 22, num. 12, p. 6608
Related resource:
ISSN: 1661-6596
Appears in Collections:Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Files in This Item:
File Description SizeFormat 
713261.pdf23.16 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons